A new publication involving histrelin was released on October 20, 2026. The study, titled "Low-dose histrelin for ovulation induction in mares: a partially randomized crossover pilot study," appeared in Veterinary Research Communications. This entry marks the publication's inclusion in the scientific record as of the stated date. The listed study design is described as a partially randomized crossover pilot study. No results, outcomes, or efficacy data from the study are included in this report. Histrelin remains an approved compound, and this publication represents new academic literature referencing its use in the context described by the title. Readers interested in the full findings, methodology, or conclusions of this pilot study are encouraged to consult the original publication directly through the journal or the linked source. This brief does not interpret or summarize any data, results, or conclusions beyond confirming that the publication exists and was indexed on the date noted. For additional background on histrelin, including its regulatory status and general information, readers can refer to the compound overview.
New Publication: Low-Dose Histrelin Study for Ovulation Induction in Mares
See the full histrelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42897392/